MedTrace Logo

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning

NCT02470910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-12-11

Study results available
· View outcomes & findings →

Summary

This research study is evaluating whether a standard prostate MRI examination can improve radiation therapy planning for prostate cancer.

Conditions

  • Prostate Cancer
  • Adenocarcinoma of the Prostate Stage I
  • Adenocarcinoma of the Prostate Stage II
  • Adenocarcinoma of the Prostate Stage III

Interventions

DEVICE

Magnetic Resonance Imaging

Sponsors & Collaborators

Principal Investigators

  • Anthony D'Amico, MD, PhD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470910 on ClinicalTrials.gov